Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 22)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: BIODELIVERY SCIE -- BDSI1$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ACHN , ACEL , BDSI , IMMP , INO -- DRUGS3$4  View Abstract
5-Feb-10Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of BIODELIVERY SCIENCES INTL including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
4-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for Biodelivery Sciences International, Inc.43$65  View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for BDSI: the economy's impact on BDSI's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
1-Feb-10Zacks Investment Research Inc.N/ABIODELIVERY SCI (BDSI) Zacks Company Snapshot1$10  View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIODELIVERY SCIENCES INTL5$25  View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIODELIVERY SCIENCES INTL5$25  View Abstract
20-Jan-10Auerbach Grayson & Co., Inc.Rabee SecuritiesAUERBACH GRAYSON: Dar Es Salaam Investment Bank - UPDATE REPORT FOR 3Q2009 FINANCIAL RESULTS (Iraq)5$10  View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIODELIVERY SCIENCES INTL5$25  View Abstract
Next 12

Brokerage Reports (Showing 1 to 1 of 1)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
20-Jan-10Auerbach Grayson & Co., Inc.Rabee SecuritiesAUERBACH GRAYSON: Dar Es Salaam Investment Bank - UPDATE REPORT FOR 3Q2009 FINANCIAL RESULTS (Iraq)5$10  View Abstract

Independent Reports (Showing 1 to 10 of 21)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: BIODELIVERY SCIE -- BDSI1$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ACHN , ACEL , BDSI , IMMP , INO -- DRUGS3$4View Abstract
5-Feb-10Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of BIODELIVERY SCIENCES INTL including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
4-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for Biodelivery Sciences International, Inc.43$65View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for BDSI: the economy's impact on BDSI's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
1-Feb-10Zacks Investment Research Inc.N/ABIODELIVERY SCI (BDSI) Zacks Company Snapshot1$10View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIODELIVERY SCIENCES INTL5$25View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIODELIVERY SCIENCES INTL5$25View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIODELIVERY SCIENCES INTL5$25View Abstract
15-Jan-10Zacks Investment Research Inc.N/ABIODELIVERY SCI (BDSI) Zacks Company Snapshot1$10View Abstract
Next 11

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.